THE WHITE HOUSE Office of the Press Secretary ________________________________________________________________________ For Immediate Release October 1, 1994 PRESIDENT NAMES THREE NEW MEMBERS TO THE NATIONAL CANCER ADVISORY BOARD President Clinton today announced his intention to appoint three new members to the National Cancer Advisory Board (NCAB). "We welcome the new NCAB members and appreciate their willingness to serve as advisors for the National Cancer Institute and the National Cancer Program," the President said. "I look orward to continuing reports of progress against these diseases, which affect the health of so many people in our country." The following new Presidential appointees will serve 6- year terms on the NCAB: J. Michael Bishop, M.D. of California is a professor of microbiology & immunology, and biochemistry & biophysics at the University of California in San Francisco. He shared the 1989 Nobel Prize in Physiolo- gy or Medicine with NIH director Harold E. Varmus, M.D. for research on oncogenes. Philip S. Schein, M.D. of Pennsylvania is president, chief executive officer, and chairman of U.S. Bioscience. A pharmacologist, Schein is expert in the design and use of drugs to treat cancers. Schein has worked at the National Cancer Institute and Georgetown University, and for Smith Kline & French Laboratories in Philadelphia. He holds 4 patents in drug develop- ment and two (and one pending) for reduction of chemotherapy toxicity. He received his M.D. in 1965 from Upstate Medical Center in Syracuse, New York. Vainutis K. Vaitkevicius, M.D. of Michigan is president of the Michigan Cancer Foundation in Detroit. The Foundation recently announced a merger to consolidate the Michigan Cancer Foundation, which runs the Meyer L. Prentis Comprehensive Cancer Center of Metro- politan Detroit, with Wayne State University and the Detroit Medical Center. An expert in the treatment of cancer with drugs, Vaitkevicius received his M.D. in 1951 from J. W. Goethe University in Frankfurt, Germany, and is board-certified in internal medicine and medical oncology. First established in 1971 by the National Cancer Act, the National Cancer Advisory Board advises the Director of the National Cancer Institute (NCI) and the Secretary of Health and Human Services on scientific and policy issues, and provides the approval for grants, which are then funded by NCI according to available resources. -30-30-30-